|
Critical illness and injury are leading causes of death and disability world-wide. At a national level, research networks in a number of countries have addressed the specific needs of this patient community and the health care workers that serve it. These collaborations serve to answer research questions of broad interest that have important implications for cost-effective care (e.g., how best to manage hyperglycemia, treat systemic inflammation, and provide mechanical ventilation). The Canadian Critical Care Trials Group is a prime example of this approach, having produced a large number of seminal reports that have impacted care worldwide.
The United States Critical Illness and Injury Trials Group (USCIITG) was created to
-
Establish national priorities for critical illness and injury research
-
Promote clinical research and the application of new data to improve outcomes for the critical ill or injured across the age (developmental) continuum
-
Stimulate interaction among existing federally-funded programs for critical illness and injury (NIH, DOD, NSF, DARPA, etc.)
-
Foster effective partnerships between federal agencies, academia, community practitioners, and industry
The USCIITG is funded by a grant from the National Institutes of General Medical Sciences, with support from staff of the NIH Clinical Center, NIH National Center for Research Resources, National Heart, Lung and Blood Institute, NIH Center for Information Technology, National Institutes of Neurological Disorders and Stroke, and the National Institute of Child Health and Development.
The inaugural meeting of the USCIITG was held on the NIH Bethesda Campus, November 18-19, 2008. |
|
|
|
|
|